The Arab Drug Company (EGX:ADCI)
173.17
0.00 (0.00%)
At close: Jun 4, 2025
The Arab Drug Company Cash Flow Statement
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Net Income | 184.99 | 102.82 | 82.77 | 76.3 | 101.41 | 92.8 | Upgrade
|
Depreciation & Amortization | 3.52 | 10.91 | 3.26 | 9.39 | 7.81 | 0.73 | Upgrade
|
Other Operating Activities | -33.22 | 22.03 | 1.48 | -52.82 | -72.65 | -20.3 | Upgrade
|
Operating Cash Flow | 155.29 | 135.77 | 87.51 | 32.87 | 36.58 | 73.24 | Upgrade
|
Operating Cash Flow Growth | 24.90% | 55.15% | 166.22% | -10.14% | -50.05% | 99.96% | Upgrade
|
Capital Expenditures | -127.91 | -218.95 | -63.18 | -89.92 | -28.87 | -2.53 | Upgrade
|
Investment in Securities | -67.03 | -67.03 | - | 13.88 | - | -0.7 | Upgrade
|
Other Investing Activities | 27.7 | 27.92 | 1.07 | 1.63 | 4.34 | 1.84 | Upgrade
|
Investing Cash Flow | -167.25 | -258.07 | -62.11 | -74.41 | -24.53 | -1.4 | Upgrade
|
Short-Term Debt Issued | - | - | - | 27.33 | - | - | Upgrade
|
Long-Term Debt Issued | - | 339.09 | 51.3 | 52.54 | - | - | Upgrade
|
Total Debt Issued | 23.87 | 339.09 | 51.3 | 79.87 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -44.55 | - | - | - | - | Upgrade
|
Total Debt Repaid | -107.06 | -44.55 | - | - | - | - | Upgrade
|
Net Debt Issued (Repaid) | -83.19 | 294.54 | 51.3 | 79.87 | - | - | Upgrade
|
Common Dividends Paid | -59.62 | -36.1 | -37.49 | -43.54 | -38.85 | -32.2 | Upgrade
|
Other Financing Activities | -46.32 | -23.09 | -1.68 | -0.95 | - | - | Upgrade
|
Financing Cash Flow | -189.13 | 235.35 | 12.13 | 35.38 | -38.85 | -32.2 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 58.24 | 69.18 | -27.33 | - | -0 | - | Upgrade
|
Net Cash Flow | -142.85 | 182.24 | 10.2 | -6.15 | -26.8 | 39.64 | Upgrade
|
Free Cash Flow | 27.38 | -83.19 | 24.33 | -57.04 | 7.71 | 70.7 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | -89.09% | 123.21% | Upgrade
|
Free Cash Flow Margin | 2.67% | -10.59% | 3.84% | -11.29% | 1.44% | 13.58% | Upgrade
|
Free Cash Flow Per Share | 4.06 | -13.86 | 4.05 | -8.42 | 1.11 | 9.52 | Upgrade
|
Cash Interest Paid | 11.64 | 23.09 | 1.68 | 0.95 | - | - | Upgrade
|
Cash Income Tax Paid | 10.75 | 34.73 | 35.09 | 51.95 | 52.97 | 24.45 | Upgrade
|
Levered Free Cash Flow | -72.69 | -110.04 | -24.95 | -121.56 | -1.96 | 51.41 | Upgrade
|
Unlevered Free Cash Flow | -43.74 | -95.61 | -23.5 | -120.96 | -1.93 | 51.41 | Upgrade
|
Change in Net Working Capital | 76.21 | -38.62 | 24.26 | 97.17 | 57.25 | 20.09 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.